 |
Articles: Pharmacokinetics |
Prior Articles
A diffusion-adjusted regional blood flow model to predict solute kinetics during haemodialysis
Nephrology Dialysis Transplantation, 04/21/09
Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
Nephrology Dialysis Transplantation, 04/21/09 Pharmacodynamics of 2-{4-[(1E)-1-(Hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl}ethan-1-ol (GDC-0879), a Potent and Selective B-Raf Kinase Inhibitor: Understanding Relationships between Systemic Concentrations, Phosphorylated Mitogen-Activated Protein Kinase Kinase 1 Inhibition, and Efficacy
Journal of Pharmacology and Experimental Therapeutics, 04/20/09 Transport of Lamivudine [(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3
Journal of Pharmacology and Experimental Therapeutics, 04/20/09 Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients
International Clinical Psychopharmacology, 04/20/09 Mixed-Effects Modeling of the Influence of Midazolam on Propofol Pharmacokinetics
Anesthesia & Analgesia, 04/17/09 Population pharmacokinetic modelling of repaglinide in healthy volunteers by using Non-Parametric Adaptive Grid Algorithm
Journal of Clinical Pharmacy and Therapeutics, 04/17/09 The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
Nephrology Dialysis Transplantation, 04/15/09 Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-d-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors
Neuropharmacology, 04/15/09 The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic MDEA and its Single Enantiomers
Drug Metabolism and Disposition, 04/14/09 CYP2B6 (c.516G-T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients
British Journal of Clinical Pharmacology, 04/14/09 In vitro and in vivo glucuronidation of midazolam in humans
British Journal of Clinical Pharmacology, 04/14/09 Population Pharmacokinetics of Ketorolac in Neonates and Young Infants
American Journal of Therapeutics, 04/14/09 Clinical Pharmacokinetics of Gentamicin
Medical Principles and Practice, 04/13/09 Bioequivalence and non-inferiority trials
Current Anaesthesia and Critical Care, 04/09/09 Lack of age and gender effects on single-dose pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem
British Journal of Clinical Pharmacology, 04/08/09 The 8th and 9th transmembrane domains in organic anion transporting polypeptide (OATP) 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17 beta-D-glucuronide
Journal of Pharmacology and Experimental Therapeutics, 04/08/09 Effects of UGT1A1 28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics
British Journal of Clinical Pharmacology, 04/07/09 Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation
Clinical Therapeutics, 04/06/09 Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 (mu)g and fluticasone propionate 250 (mu)g: Implications for establishing bioequivalence of inhaled products
Clinical Therapeutics, 04/06/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
